A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant | MicrobiomeTrials← Back to trialsNCT07023081
A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-06-15Est. Completion: 2027-06-10
Enrollment target: 200 participants Locations- Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, Guangxi, China
- Wuming District Center for Disease Control and Prevention, Chengxiang, Nanning, China
Other microbiome trials you might be interested in
Pneumococcal Disease
The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccin…
Estero, United StatesEst. completion Dec 30, 2028
Pneumococcal Disease
The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccin…
Birmingham, United StatesEst. completion Dec 2, 2027